220 studies found for:    imrt | Open Studies | Interventional Studies | cancer | Phase 2, 3
Show Display Options
Rank Status Study
1 Recruiting PET-Adjusted Intensity Modulated Radiation Therapy and Combination Chemotherapy in Treating Patients With Stage II-IV Non-Small Cell Lung Cancer
Conditions: Recurrent Non-small Cell Lung Cancer;   Stage IIA Non-small Cell Lung Cancer;   Stage IIB Non-small Cell Lung Cancer;   Stage IIIA Non-small Cell Lung Cancer;   Stage IIIB Non-small Cell Lung Cancer;   Stage IV Non-small Cell Lung Cancer;   Tumors Metastatic to Brain
Interventions: Procedure: positron emission tomography;   Procedure: computed tomography;   Radiation: intensity-modulated radiation therapy;   Drug: carboplatin;   Drug: paclitaxel
2 Recruiting Efficacy of Intensity Modulated Radiation Therapy After Surgery in Early Stage of Esophageal Carcinoma;
Conditions: Esophageal Neoplasm;   Esophageal Cancer TNM Staging Primary Tumor (T) T2;   Esophageal Cancer TNM Staging Primary Tumor (T) T3;   Esophageal Cancer TNM Staging Regional Lymph Nodes (N) N0;   Esophageal Cancer TNM Staging Distal Metastasis (M) M0
Intervention: Radiation: Prophylactic postoperative radiation therapy
3 Unknown  Comparison of the Cosmetic Outcome of Hypofractionated Versus Normofractionated IMRT in Treatment of Breast Cancer
Conditions: Tumors;   Breast Cancer
Intervention: Radiation: intensity modulated radiotherapy (IMRT) for breast cancer
4 Recruiting Intensity-Modulated Proton Beam Therapy (IMPT) Versus Intensity-Modulated Photon Therapy (IMRT)
Condition: Head And Neck Cancer
Interventions: Radiation: Intensity-Modulated X-Ray Therapy (IMRT);   Radiation: Intensity-Modulated Proton Beam Therapy (IMPT);   Procedure: Modified barium swallow (MBS);   Behavioral: Questionnaires
5 Recruiting IMRT Plus Cisplatin Versus Conventional Radiotherapy Plus Cisplatin in Stage III-IV HNSCC
Conditions: Oral Cancer;   Oropharynx Cancer;   Hypopharynx Cancer
Interventions: Procedure: IMRT 75 Gy;   Procedure: Conventional radiotherapy 70 Gy;   Drug: concomitant cisplatin
6 Unknown  Whole Breast Irradiation With Intensity Modulated Radiotherapy and Simultaneously Integrated Boost for Early Stage Breast Cancer Patients
Condition: Breast Cancer
Intervention: Radiation: IMRT with an simultaneous integrated boost
7 Not yet recruiting Study of I-125 Brachytherapy Versus Intensity-modulated Radiation Therapy to Treat Inoperable Salivary Gland Cancer
Condition: Salivary Gland Cancer
Interventions: Radiation: brachytherapy;   Radiation: IMRT
8 Recruiting 3D-Conformal Radiation vs Helical Tomotherapy in Prostate Cancer
Condition: Prostate Cancer
Interventions: Radiation: Arm B: Helical Tomotherapy Intensity Modulated Radiotherapy;   Other: Arm A: 3D-Conformal Radiation
9 Recruiting Postoperative IMRT Combined With Capecitabine for Advanced Gastric Cancer Patients
Condition: Gastric Cancer
Intervention: Radiation: concurrent chemoradiation
10 Recruiting Radiation Therapy, Gemcitabine Hydrochloride, and Cisplatin in Treating Patients With Locally Advanced Squamous Cell Carcinoma of the Vulva
Conditions: Squamous Cell Carcinoma of the Vulva;   Stage IIIA Vulvar Cancer;   Stage IIIB Vulvar Cancer;   Stage IIIC Vulvar Cancer;   Stage IVA Vulvar Cancer
Interventions: Radiation: intensity-modulated radiation therapy;   Drug: gemcitabine hydrochloride;   Drug: cisplatin;   Procedure: therapeutic conventional surgery
11 Recruiting Intensity-modulated Radiotherapy for Locally Advanced Cervical Cancer
Condition: Locally Advanced Cervical Cancer
Interventions: Radiation: intensity modulated radiotherapy;   Procedure: Intracavitary brachytherapy;   Drug: Cisplatin
12 Recruiting Consolidation Whole Abdominal Intensity-Modulated Radiation Therapy (IMRT) in Advanced Ovarian Cancer
Conditions: Ovarian Cancer;   Tubal Carcinoma;   Primary Peritoneal Carcinoma
Intervention: Radiation: intensity-modulated whole-abdominal radiotherapy
13 Recruiting Intensity-Modulated Radiation Therapy (IMRT) in the Treatment of Non-Anaplastic Non-Medullary Thyroid Cancer
Condition: Thyroid Cancer
Interventions: Radiation: IMRT;   Device: DWI MRI;   Drug: Doxorubicin
14 Recruiting Proton Therapy vs. IMRT for Low or Intermediate Risk Prostate Cancer
Condition: Prostate Cancer
Interventions: Radiation: Proton Beam Therapy;   Radiation: Intensity Modulated Radiation Therapy
15 Recruiting Intensity-Modulated Radiation Therapy and Paclitaxel With or Without Pazopanib Hydrochloride in Treating Patients With Anaplastic Thyroid Cancer
Condition: Anaplastic Thyroid Cancer
Interventions: Drug: paclitaxel;   Drug: pazopanib hydrochloride;   Other: placebo;   Radiation: intensity-modulated radiation therapy
16 Not yet recruiting Phase I-II Study on Treatment of Advanced Oropharynx Cancer in Elderly Population by Intensity Modulated Radiotherapy With Treatment Volume Reduction and Combination Chemotherapy
Condition: Head and Neck Cancer
Intervention: Radiation: Modulated radiotherapy (IMRT) using RapidArc® or Helical Tomotherapy® at a dose of 70 Gy in 33 fractions to the PTV (GTV) and 59.4 Gy in 33 fractions
17 Unknown  Preoperative Concurrent Chemotherapy and Intensity Modulated Radiotherapy (IMRT) in Locally Advanced Rectal Cancer
Condition: Rectal Cancers.
Intervention: Radiation: Intensity Modulated Radiotherapy
18 Recruiting Phase III Study Comparing 3D Conformal Radiotherapy and Conformal Radiotherapy IMRT to Treat Endometrial Cancer
Condition: Endometrial Cancer
Interventions: Radiation: 3D conformational radiation;   Radiation: IMRT
19 Recruiting Pre-operative 3-DCRT vs IMRT for Locally Advanced Rectal Cancer
Condition: Locally Advanced Rectal Cancer
Intervention: Radiation: IMRT
20 Recruiting Radiation Therapy With Cisplatin, Docetaxel, or Cetuximab After Surgery in Treating Patients With Stage III-IV Squamous Cell Head and Neck Cancer
Conditions: Stage III Squamous Cell Carcinoma of the Hypopharynx;   Stage III Squamous Cell Carcinoma of the Larynx;   Stage III Squamous Cell Carcinoma of the Lip and Oral Cavity;   Stage III Squamous Cell Carcinoma of the Oropharynx;   Stage III Verrucous Carcinoma of the Larynx;   Stage III Verrucous Carcinoma of the Oral Cavity;   Stage IV Squamous Cell Carcinoma of the Hypopharynx;   Stage IVA Squamous Cell Carcinoma of the Larynx;   Stage IVA Squamous Cell Carcinoma of the Lip and Oral Cavity;   Stage IVA Squamous Cell Carcinoma of the Oropharynx;   Stage IVA Verrucous Carcinoma of the Larynx;   Stage IVA Verrucous Carcinoma of the Oral Cavity;   Stage IVB Squamous Cell Carcinoma of the Larynx;   Stage IVB Squamous Cell Carcinoma of the Lip and Oral Cavity;   Stage IVB Squamous Cell Carcinoma of the Oropharynx;   Stage IVB Verrucous Carcinoma of the Larynx;   Stage IVB Verrucous Carcinoma of the Oral Cavity;   Tongue Cancer
Interventions: Drug: cisplatin;   Drug: docetaxel;   Biological: cetuximab;   Other: laboratory biomarker analysis;   Procedure: quality-of-life assessment;   Radiation: intensity-modulated radiation therapy

Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results
Indicates status has not been verified in more than two years